EconomyLens.com
No Result
View All Result
Friday, November 20, 2026
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
EconomyLens.com
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
No Result
View All Result
EconomyLens.com
No Result
View All Result
Home Business

US judge approves $7.25 bn Roundup cancer settlement

Emma Reilly by Emma Reilly
November 20, 2026
in Business
Reading Time: 6 mins read
A A
2
19
SHARES
235
VIEWS
Share on FacebookShare on Twitter

Bayer has spent billions of dollars settling thousands of cases linked to Roundup since it acquired the weedkiller's producer, the US agrichemical group Monsanto, in 2018. ©AFP

Washington (United States) (AFP) – A US judge on Friday approved Bayer’s $7.25 billion settlement of lawsuits over claims its Roundup weedkiller caused blood cancer, in one of the largest class-action payouts in US history. The decision paves the way for compensation to tens of thousands of people who were exposed to the glyphosate-based herbicide and have been diagnosed with Non-Hodgkin lymphoma (NHL). It also covers people who were exposed to Roundup and go on to develop the illness in the future.

Related

Grand Theft Auto VI takes record $3.8 bn on first day

NFL legend Brady in talks over buying Chelsea stake: reports

Lufthansa plans 1,000 job cuts on slow turnaround, fuel costs

German union vows to fight VW’s ‘catalogue of horrors’

Clubs vote for extra legal protection for Premier League chiefs amid Man City case

The Missouri state court “fully and finally approves the Settlement Agreement in its entirety,” Judge Timothy Boyer said in his ruling. “Today is a real good day,” Christopher Seeger, a court-appointed lead attorney for plaintiffs already diagnosed with NHL, told AFP by phone. People with diagnosed NHL will receive payments of between $10,000 to $165,000, depending on a range of factors including whether they were residential or occupational users of Roundup, such as landscapers.

Approval of the settlement was “really the only path that most victims of Roundup will have to compensation,” Seeger said, because in June, the US Supreme Court sided with Bayer in a case and ruled it would no longer allow “failure-to-warn” claims in US states. The Supreme Court concluded that the US Environmental Protection Agency’s determination that Roundup is not a carcinogen pre-empts claims in state courts tying the product to a cancer diagnosis. Seeger explained that those claims had been the most viable path for most plaintiffs. This settlement was reached before the Supreme Court ruling, but both sides had agreed to honor it whatever the outcome.

People who never filed a case but were exposed to Roundup can still apply for compensation if they develop NHL in the coming years and if they meet certain conditions. Bayer has spent billions of dollars settling thousands of cases linked to Roundup since it acquired the weedkiller’s producer, the US agrichemical group Monsanto, in 2018. In a statement to AFP, it said it hoped the settlement, together with the Supreme Court decision, would help draw a line under litigation. “The Court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” said CEO Bill Anderson.

The World Health Organization’s International Agency for Research on Cancer in 2015 designated glyphosate, Roundup’s main active ingredient, a probable human carcinogen, but Bayer says scientific studies and regulatory approvals show the weedkiller is safe. Last year, a highly influential decades-old study that declared Roundup posed no serious health risks was retracted, ending a decades-long saga that exposed how corporate interests can distort scientific research and influence government decision-making. In its retraction note, the Regulatory Toxicology and Pharmacology journal cited a litany of serious flaws, ranging from the omission of carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees.

Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT. But its soaring use — especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops — drew increasing scrutiny in the 1990s. Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer said it was phasing out Roundup for US residential use in 2023 in response to growing lawsuits.

© 2024 AFP

Tags: compensationhealthcarelawsuit
Share8Tweet5Share1Pin2Send
Previous Post

Anthropic IPO fails to calm AI jitters as tech stocks plummet

Emma Reilly

Emma Reilly

Related Posts

Business

Pochettino vows to ease pressure on struggling Man Utd players

November 19, 2026
Business

Amazon warns New York labor bill could hike order costs

November 19, 2026
Business

Germany agrees terms with Italy’s UniCredit for Commerzbank takeover

November 19, 2026
Business

Leicester split with sponsor after row over porn actor partnership

November 19, 2026
Business

Turkey revels in new status within NATO defence industry

November 19, 2026
Business

Musk says he feels ‘pretty foolish’ for failed US election spending

November 18, 2026
0 0 votes
Article Rating
Subscribe
Notify of
guest
guest
2 Comments
Oldest
Newest Most Voted
  • Trending
  • Comments
  • Latest

New York ruling deals Trump business a major blow

September 30, 2024

Elon Musk’s X fights Australian watchdog over church stabbing posts

April 21, 2024

Women journalists bear the brunt of cyberbullying

April 22, 2024

France probes TotalEnergies over 2021 Mozambique attack

May 6, 2024

New York ruling deals Trump business a major blow

104

Ghanaian finance ministry warns against fallout from anti-LGBTQ law

74

Shady bleaching jabs fuel health fears, scams in W. Africa

71

Stock markets waver, oil prices edge up

65

US judge approves $7.25 bn Roundup cancer settlement

November 20, 2026

Anthropic IPO fails to calm AI jitters as tech stocks plummet

November 20, 2026

Trump calls for Nvidia’s Huang to be given ‘second chance’

November 20, 2026

Grand Theft Auto VI takes record $3.8 bn on first day

November 20, 2026
From EconomyLens

Clear insights, straight to your inbox.

Get the stories and perspectives shaping the economy.

EconomyLens Logo

We bring the world economy to you. Get the latest news and insights on the global economy, from trade and finance to technology and innovation.

Your Privacy Choices

Pages

  • Home
  • About Us
  • Privacy Policy
  • Contact Us

Categories

  • Business
  • Economy
  • Markets
  • Tech
  • Editorials

Network

  • Coolinarco.com
  • CasualSelf.com
  • Fit.CasualSelf.com
  • Sport.CasualSelf.com
  • SportBeep.com
  • MachinaSphere.com
  • MagnifyPost.com
  • TodayAiNews.com
  • VideosArena.com
© 2026 EconomyLens.com - Top economic news from around the world.
No Result
View All Result
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials

© 2024 EconomyLens.com - Top economic news from around the world.